India-based Graph AI raised a $13.3 million post-seed round on September 10, 2026, from Insight Partners and Bessemer. Its software automates pharmaceutical safety and adverse-event reporting for drugmakers.
Graph AI raises $13.3M for pharma safety and adverse-event software
Compliance-heavy verticals like pharmacovigilance are drawing top-tier AI investment; founders in regulated niches can cite this to argue their category is fundable, not too narrow.
Source: TechStartups
More that helps you.
Arintra raises $25M Series B for autonomous medical coding AI
Arintra raised a $25 million Series B announced the week of Aug 24-26, 2026, led by Define Ventures with Peak XV Partners and Y Combinator, bringing total funding to $51 million. I…
Evvy raises $40M Series B for AI-powered women's health diagnostics
Evvy, a precision-medicine company offering vaginal microbiome testing, AI-powered diagnostics and personalized care for women's health, raised a $40M Series B on September 16, 202…
Inspiren raises $70M Series C to run AI in senior living
Inspiren announced a $70 million Series C on September 10, 2026, with NewView Capital and Insight Partners among the backers. Its platform applies AI to operations inside senior-li…
Stockholm's Tandem Health raises $100M Series B for an AI clinical operating system
Tandem Health raised EUR 86.49 million (about $100 million) in a Series B led by the EQT-managed Scaleup Europe Fund, announced September 14, 2026. The startup is expanding from AI…
Get briefs like this tuned to you.
In the app, Founder Briefs are personalized to your country, industry and stage, and you can save the ones that matter.
See plans →